NTLA
Intellia Therapeutics, Inc. · Healthcare
President and CEO John M Leonard sold $248K of Intellia Therapeutics, Inc.
Sold$248,302
$37.21Price
6,673Shares
−1%Stake
What NTLA did after the filing
- The stock from Mon, Jan 9 open, $38.37
- +1.5%
- S&P 500, same days
- +2.1%
Measured over 30 trading days, to the Feb 22 close.
Traded Wed, Jan 4. Filed Fri, Jan 6, 5:32 PM ET, after the close. Returns use the Jan 9 open and the Feb 22 close. Not investment advice.